[CLINICAL TRIAL AND THERAPY WITH A NEW SYNTHETIC ANTICHOLINERGIC AGENT: THE BENZYL ESTER OF 1,1-DIETHYL-3-HYDROXYPYRROLIDINIUM BROMIDE].
D035843:Biomedical Research; D001965:Bromides; D018680:Cholinergic Antagonists; D004358:Drug Therapy; D004381:Duodenal Ulcer; D005756:Gastritis; D005853:Geriatrics; D010276:Parasympatholytics; D013276:Stomach Ulcer
D001965:Bromides; D018680:Cholinergic Antagonists; D010276:Parasympatholytics
CLINICAL RESEARCH; DRUG THERAPY; DUODENAL ULCER; GASTRITIS; GERIATRICS; PARASYMPATHOLYTICS; STOMACH ULCER
ESSAI CLINIQUE ET TH'ERAPEUTIQUE D'UN NOUVEL ANTICHOLINERGIQUE DE SYNTH'ESE: L'ESTER-BENZYLIQUE DU BROMURE DE 1-1-DIETHYL-3-HYDROXY-PYRROLIDINIUM.